New York State Common Retirement Fund grew its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 2.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 457,700 shares of the medical equipment provider’s stock after acquiring an additional 8,984 shares during the period. New York State Common Retirement Fund owned 0.23% of Zimmer Biomet Holdings worth $58,769,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. BlackRock Inc. lifted its position in shares of Zimmer Biomet Holdings by 4.1% during the second quarter. BlackRock Inc. now owns 17,419,463 shares of the medical equipment provider’s stock worth $2,236,657,000 after acquiring an additional 679,080 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Zimmer Biomet Holdings by 3.7% in the first quarter. Vanguard Group Inc. now owns 13,041,411 shares of the medical equipment provider’s stock worth $1,592,488,000 after buying an additional 464,916 shares in the last quarter. State Street Corp raised its position in shares of Zimmer Biomet Holdings by 2.4% in the first quarter. State Street Corp now owns 8,193,165 shares of the medical equipment provider’s stock worth $1,000,463,000 after buying an additional 191,747 shares in the last quarter. Longview Partners Guernsey LTD raised its position in shares of Zimmer Biomet Holdings by 4.4% in the second quarter. Longview Partners Guernsey LTD now owns 6,377,711 shares of the medical equipment provider’s stock worth $818,898,000 after buying an additional 269,184 shares in the last quarter. Finally, Nordea Investment Management AB raised its position in shares of Zimmer Biomet Holdings by 25.0% in the first quarter. Nordea Investment Management AB now owns 4,931,281 shares of the medical equipment provider’s stock worth $602,159,000 after buying an additional 987,398 shares in the last quarter. Hedge funds and other institutional investors own 85.35% of the company’s stock.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $121.74, for a total value of $2,067,875.64. The sale was disclosed in a filing with the SEC, which is available through this link. 1.07% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: “New York State Common Retirement Fund Buys 8,984 Shares of Zimmer Biomet Holdings, Inc. (ZBH)” was published by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.watchlistnews.com/new-york-state-common-retirement-fund-buys-8984-shares-of-zimmer-biomet-holdings-inc-zbh/1578131.html.

Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) opened at 116.22 on Thursday. The stock has a market capitalization of $23.50 billion, a price-to-earnings ratio of 33.10 and a beta of 1.21. Zimmer Biomet Holdings, Inc. has a one year low of $95.63 and a one year high of $133.49. The firm has a 50-day moving average of $114.50 and a 200 day moving average of $120.75.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the Zacks’ consensus estimate of $2.10 by ($0.02). The company had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. Zimmer Biomet Holdings’s revenue was up 1.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.02 earnings per share. On average, equities research analysts predict that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be paid a $0.24 dividend. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 dividend on an annualized basis and a yield of 0.83%. Zimmer Biomet Holdings’s dividend payout ratio is currently 27.59%.

A number of equities research analysts recently issued reports on ZBH shares. Zacks Investment Research downgraded Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 8th. Morgan Stanley increased their price objective on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, July 17th. Oppenheimer Holdings, Inc. set a $137.00 price objective on Zimmer Biomet Holdings and gave the stock a “buy” rating in a research report on Monday, August 14th. BMO Capital Markets reiterated a “buy” rating and issued a $136.00 price objective on shares of Zimmer Biomet Holdings in a research report on Tuesday, July 11th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $141.00 price objective on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. Zimmer Biomet Holdings currently has an average rating of “Hold” and an average target price of $136.75.

Zimmer Biomet Holdings Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.